Derek Gould
Logos Global Management Lp
Assets Managed
$2.003B
Holdings
63
Last Quarter
2026 - Q1
Filed Date
19d ago
Growth Rate
21.03%(2Q avg: 34.69%)
Sustained Growth
4 quarters
Portfolio positions
This chart displays the top 10 holdings in Logos Global Management Lp's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 63 positions.
Assets under management
The assets under management (AUM) of Logos Global Management Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 4 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 2.003B in assets, with a quarterly growth rate of 21.03% and a 2-quarter average growth rate of 34.69%. The portfolio is managed by Derek Gould, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
RVMD Revolution Medicines Inc
| 9.72% | $194.5M 2M shares@ $97.25 avg price | Decreased -33.33% |
ERAS Erasca Inc
| 9.01% | $180.407M 11.15M shares@ $16.18 avg price | Decreased -14.23% |
IDYA Ideaya Biosciences Inc
| 5.74% | $114.954M 3.45M shares@ $33.32 avg price | Decreased -3.49% |
TERN Terns Pharmaceuticals Inc
| 5.27% | $105.44M 2M shares@ $52.72 avg price | Increased 166.67% |
PRAX Praxis Precision Medicines I
| 4.59% | $91.824M 285,000 shares@ $322.19 avg price | Decreased -24% |
CNTA Centessa Pharmaceuticals-adr
| 4.22% | $84.405M 2.125M shares@ $39.72 avg price | Increased 962.5% |
ABVX Abivax Sa-adr
| 3.76% | $75.161M 675,000 shares@ $111.35 avg price | Increased 68.75% |
TNGX Tango Therapeutics Inc
| 3.14% | $62.76M 3M shares@ $20.92 avg price | Decreased -28.57% |
CYTK Cytokinetics Inc
| 2.88% | $57.671M 875,000 shares@ $65.91 avg price | Increased 191.67% |
OLMA Olema Pharmaceuticals Inc
| 2.39% | $47.844M 3.209M shares@ $14.91 avg price |
1-10 of 63